Comerica Bank
LGND icon

Comerica Bank’s Ligand Pharmaceuticals LGND Stock Holding History

Comerica Bank’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.03M Sell
5,432
-1,103
-17% -$212K ﹤0.01% 1496
2025
Q3 		$1.16M Sell
6,535
-1,108
-14% -$165K ﹤0.01% 1461
2025
Q2 		$869K Buy
7,643
+267
+4% +$28.5K ﹤0.01% 1598
2025
Q1 		$776K Sell
7,376
-214
-3% -$24.2K ﹤0.01% 1632
2024
Q4 		$813K Buy
7,590
+23
+0.3% +$2.6K ﹤0.01% 1667
2024
Q3 		$757K Buy
7,567
+282
+4% +$28.4K ﹤0.01% 1696
2024
Q2 		$614K Sell
7,285
-557
-7% -$44.3K ﹤0.01% 1747
2024
Q1 		$573K Sell
7,842
-740
-9% -$54.6K ﹤0.01% 1825
2023
Q4 		$613K Buy
8,582
+676
+9% +$39.9K ﹤0.01% 1776
2023
Q3 		$474K Buy
+7,906
New +$520K ﹤0.01% 1817
2022
Q4 		$680K Sell
9,587
-10,077
-51% -$655K 0.01% 1653
2022
Q3 		$1.06M Sell
19,664
-3,302
-14% -$194K 0.01% 1434
2022
Q2 		$1.34M Buy
22,966
+112
+0.5% +$6.36K 0.01% 1357
2022
Q1 		$1.47M Buy
22,854
+361
+2% +$26.2K 0.01% 1355
2021
Q4 		$1.64M Sell
22,493
-1,740
-7% -$161K 0.01% 1281
2021
Q3 		$2.06M Sell
24,233
-41,089
-63% -$3.18M 0.01% 1267
2021
Q2 		$4.17M Sell
65,322
-2,312
-3% -$192K 0.02% 823
2021
Q1 		$6.17M Sell
67,634
-20,904
-24% -$1.98M 0.04% 613
2020
Q4 		$7.88M Buy
88,538
+4,190
+5% +$239K 0.05% 429
2020
Q3 		$4.47M Buy
84,348
+29,721
+54% +$2.03M 0.03% 642
2020
Q2 		$4.2M Sell
54,627
-3,854
-7% -$244K 0.03% 618
2020
Q1 		$3.56M Buy
58,481
+6,844
+13% +$388K 0.03% 597
2019
Q4 		$2.89M Sell
51,637
-1,937
-4% -$129K 0.02% 871
2019
Q3 		$3.66M Buy
53,574
+12,686
+31% +$796K 0.03% 677
2019
Q2 		$2.87M Sell
40,888
-2,863
-7% -$211K 0.02% 844
2019
Q1 		$3.5M Sell
43,751
-3,478
-7% -$264K 0.03% 737
2018
Q4 		$3.42M Sell
47,229
-1,316
-3% -$140K 0.03% 725
2018
Q3 		$5.54M Sell
48,545
-3,322
-6% -$501K 0.04% 463
2018
Q2 		$7.17M Sell
51,867
-1,274
-2% -$142K 0.05% 413
2018
Q1 		$5.59M Buy
53,141
+6,013
+13% +$595K 0.04% 541
2017
Q4 		$4.82M Buy
47,128
+4,599
+11% +$399K 0.03% 686
2017
Q3 		$3.79M Buy
42,529
+9,767
+30% +$773K 0.03% 782
2017
Q2 		$2.53M Sell
32,762
-1,614
-5% -$113K 0.02% 1037
2017
Q1 		$2.38M Buy
34,376
+1,305
+4% +$85.9K 0.02% 1109
2016
Q4 		$2.18M Buy
33,071
+1,772
+6% +$112K 0.02% 1139
2016
Q3 		$1.92M Buy
31,299
+462
+1% +$33.9K 0.02% 1105
2016
Q2 		$2.22M Buy
30,837
+1,319
+4% +$97.9K 0.02% 980
2016
Q1 		$2.29M Buy
29,518
+47
+0.2% +$2.86K 0.02% 929
2015
Q4 		$1.8M Buy
29,471
+234
+0.8% +$14.4K 0.02% 1046
2015
Q3 		$1.56M Sell
29,237
-28,731
-50% -$1.74M 0.01% 1179
2015
Q2 		$3.65M Buy
57,968
+29,595
+104% +$1.61M 0.02% 1141
2015
Q1 		$1.36M Sell
28,373
-28,575
-50% -$1.09M 0.01% 1316
2014
Q4 		$1.89M Buy
56,948
+27,054
+90% +$880K 0.01% 1514
2014
Q3 		$876K Sell
29,894
-2,570
-8% -$85.3K 0.01% 1550
2014
Q2 		$1.26M Sell
32,464
-183
-0.6% -$7.43K 0.01% 1381
2014
Q1 		$1.37M Sell
32,647
-981
-3% -$40.9K 0.01% 1367
2013
Q4 		$1.1M Buy
+33,628
New +$1.1M 0.01% 1500

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Comerica Bank's LGND Position: Q4 2025 in Review

Comerica Bank reduced its Ligand Pharmaceuticals (LGND) stake by 17% in Q4 2025, selling an estimated $212K and leaving 5,432 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1496.

Comerica Bank first reported a position in LGND in Q4 2013 and has held it in 47 quarters since. The position peaked at $7.88M in Q4 2020. 349 funds tracked by Wall St. Rank hold LGND as of Q4 2025.

  • Comerica Bank held 5,432 shares of Ligand Pharmaceuticals worth $1.03M as of Q4 2025.
  • Comerica Bank sold 1,103 Ligand Pharmaceuticals shares in Q4 2025, an estimated $212K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1496 holding.
  • Comerica Bank first reported a position in Ligand Pharmaceuticals in Q4 2013 and has held it in 47 quarters since.
  • Comerica Bank's Ligand Pharmaceuticals position peaked at $7.88M in Q4 2020.
  • 349 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.